Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-1990 | 07-1990 | 04-1990 | 01-1990 | 10-1989 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,755 | N/A | N/A | N/A | 6,074 |
| Depreciation Amortization | 1,620 | N/A | N/A | N/A | 1,836 |
| Other Working Capital | -846 | N/A | N/A | N/A | -4,408 |
| Other Operating Activity | 355 | 0 | 0 | 0 | -348 |
| Operating Cash Flow | $6,884 | $N/A | $N/A | $N/A | $3,154 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,042 | N/A | N/A | N/A | -2,032 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -257 |
| Other Investing Activity | -4,291 | 0 | 0 | 0 | 269 |
| Investing Cash Flow | $-5,333 | $N/A | $N/A | $N/A | $-2,020 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 97 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -3,462 | 0 | 0 | 0 | -206 |
| Financing Cash Flow | $-3,365 | $N/A | $N/A | $N/A | $-206 |
| Beginning Cash Position | 5,614 | N/A | N/A | N/A | 4,686 |
| End Cash Position | 3,800 | N/A | N/A | N/A | 5,614 |
| Net Cash Flow | $-1,814 | $N/A | $N/A | $N/A | $928 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,884 | N/A | N/A | N/A | 3,154 |
| Free Cash Flow | 6,884 | 0 | 0 | 0 | 3,154 |